Mar 22 | Sep 21 | Mar 21 | Sep 20 | Mar 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 5.40M | £ 8.10M | £ 300.00K | £ 2.90M | £ 500.00K |
Total Assets | £ 305.10M | £ 305.40M | £ 302.80M | £ 309.90M | £ 310.40M |
Total Debt | £ 67.00M | £ 69.50M | £ 79.10M | £ 69.50M | £ 65.90M |
Net Debt | £ 61.60M | £ 61.40M | £ 78.80M | £ 66.60M | £ 65.40M |
Total Liabilities | £ 92.50M | £ 122.60M | £ 126.30M | £ 137.20M | £ 132.90M |
Stockholders Equity | £ 212.60M | £ 182.80M | £ 176.50M | £ 172.70M | £ 177.50M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |